BR0108448A - Derivados de tetraidrofuril óxi-e amino-substituìdos com atividade antitumor - Google Patents
Derivados de tetraidrofuril óxi-e amino-substituìdos com atividade antitumorInfo
- Publication number
- BR0108448A BR0108448A BR0108448-8A BR0108448A BR0108448A BR 0108448 A BR0108448 A BR 0108448A BR 0108448 A BR0108448 A BR 0108448A BR 0108448 A BR0108448 A BR 0108448A
- Authority
- BR
- Brazil
- Prior art keywords
- substituted
- unsubstituted
- amino
- antitumor activity
- alkenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/22—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
"DERIVADOS DE TETRAIDROFURIL óXI- E AMINO-SUBSTITUìDOS COM ATIVIDADE ANTITUMOR". Os compostos de fórmula (I), em que os grupos substituintes definidos por R~ 1~, R~ 2~, R~ 3~ e R~ 4~ são, cada um, independentemente selecionados de H, C(=O)R, P(=O)R'R", S(=O)R'R", C~ 1~-C~ 18~ alquila substituída ou não substituída, C~ 2~-C~ 18~ alquenila substituída ou não-substituída, C~ 2~-C~ 18~ alquinila substituída ou não-substituída, arila substituída ou não-substituída; em que cada um dos grupos R', R" é independentemente selecionado a partir do grupo consistindo em H, OH, NO~ 2~, NH~ 2~, SH, CN, halogênio, =O, C(=O)H, C(=O)CH~ 3~, CO~ 2~H, CO~ 2~CH~ 3~, C~ 1~-C~ 18~ alquila substituída ou não-substituída, C~ 2~C~ 18~ alquenila substituída ou não-substituída, C~ 2~-C~ 18~ alquinila substituída ou não-substituída, arila substituída ou não-substituída; em que R~ 1~, R~ 2~, R~ 3~ poderiam formar parte de um anel heterocíclico; R~ 2~ pode ser independentemente um sal interno; em que X~ 1~, X~ 2~ e X~ 3~ na fórmula (I) são independentemente colocados em qualquer posição particular da cadeia e independentemente selecionados de H, OH, OR', SH, SR', SOR', SO~ 2~R', NO~ 2~, NH~ 2~, NHR', N(R')~ 2~, NHC(O)R', CN, halogênio, =O, C(=O)H, C(=O)CH~ 3~, CO~ 2~H, CO~ 2~CH~ 3~, C~ 1~-C~ 18~ alquila substituída ou não-substituída, C~ 2~-C~ 18~ alquenila substituída ou não-substituída, C~ 2~-C~ 18~ alquinila substituída ou não substituída, arila substituída ou não-substituída, heteroaromático substituído ou não-substituído; em que os grupos substituintes definidos por R' são, cada um, independentemente selecionados do grupo consistindo em H, OH, OR', SH, SR', SOR', SO~ 2~R', NO~ 2~, NH~ 2~, NHR', N(R')~ 2~, NHC(O)R', CN, halogênio, =O, C(=O)H, C(=O)CH~ 3~, CO~ 2~H, CO~ 2~CH~ 3~, C~ 1~-C~ 18~ alquila substituída ou não-substituída, C~ 2~-C~ 18~ alquenila substituída ou não-substituída, C~ 2~-C~ 18~ alquinila substituída ou não-substituída, arila substituída ou não-substituída, heteroaromático substituído ou não-substituído; em que x pode ser entre 6 e 20; e em que a linha pontilhada é uma ou diversas ligações duplas colocadas em qualquer posição particular da cadeia lateral; são úteis como compostos antitumor e incluem o composto IK-8-73-4 de estrutura (a), o qual foi isolado de uma esponja Pachastrissa sp.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0003629A GB0003629D0 (en) | 2000-02-16 | 2000-02-16 | Antitumour agent |
GB0021774A GB0021774D0 (en) | 2000-09-05 | 2000-09-05 | Anti-tumour compound |
PCT/GB2001/000655 WO2001060810A1 (en) | 2000-02-16 | 2001-02-16 | Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0108448A true BR0108448A (pt) | 2003-04-01 |
Family
ID=26243662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0108448-8A BR0108448A (pt) | 2000-02-16 | 2001-02-16 | Derivados de tetraidrofuril óxi-e amino-substituìdos com atividade antitumor |
Country Status (17)
Country | Link |
---|---|
US (1) | US6864283B2 (pt) |
EP (1) | EP1255746B1 (pt) |
JP (1) | JP2003523338A (pt) |
KR (1) | KR20020092958A (pt) |
CN (1) | CN1318409C (pt) |
AT (1) | ATE316524T1 (pt) |
AU (2) | AU3387301A (pt) |
BR (1) | BR0108448A (pt) |
CA (1) | CA2400612C (pt) |
CZ (1) | CZ20022791A3 (pt) |
DE (1) | DE60116855T2 (pt) |
ES (1) | ES2256199T3 (pt) |
IL (1) | IL151241A (pt) |
MX (1) | MXPA02007995A (pt) |
PL (1) | PL357193A1 (pt) |
RU (1) | RU2002124591A (pt) |
WO (1) | WO2001060810A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1255746B1 (en) | 2000-02-16 | 2006-01-25 | Pharma Mar, S.A. | Oxy- and amino-substituted tetrahydrofuryl derivatives with antimour activity |
CN102229585A (zh) * | 2011-04-26 | 2011-11-02 | 中国人民解放军第二军医大学 | 具有抗肿瘤活性的γ-丁内酯聚酮类化合物 |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2007507C (en) | 1989-02-03 | 1998-05-19 | Yasuyuki Igarashi | Sphingosine and n-methyl-sphingosine as inhibitor of cell growth |
US5583160A (en) * | 1989-02-03 | 1996-12-10 | The Biomembrane Institute | Methylsphingosine used to treat apoptosis |
US6107520A (en) * | 1997-04-15 | 2000-08-22 | The Board Of Trustees Of The University Of Illinois | Spisulosine compounds |
EP1255746B1 (en) | 2000-02-16 | 2006-01-25 | Pharma Mar, S.A. | Oxy- and amino-substituted tetrahydrofuryl derivatives with antimour activity |
-
2001
- 2001-02-16 EP EP01905903A patent/EP1255746B1/en not_active Expired - Lifetime
- 2001-02-16 RU RU2002124591/04A patent/RU2002124591A/ru not_active Application Discontinuation
- 2001-02-16 CN CNB018080421A patent/CN1318409C/zh not_active Expired - Fee Related
- 2001-02-16 WO PCT/GB2001/000655 patent/WO2001060810A1/en active IP Right Grant
- 2001-02-16 MX MXPA02007995A patent/MXPA02007995A/es active IP Right Grant
- 2001-02-16 JP JP2001560195A patent/JP2003523338A/ja active Pending
- 2001-02-16 ES ES01905903T patent/ES2256199T3/es not_active Expired - Lifetime
- 2001-02-16 AU AU3387301A patent/AU3387301A/xx active Pending
- 2001-02-16 BR BR0108448-8A patent/BR0108448A/pt not_active IP Right Cessation
- 2001-02-16 CA CA2400612A patent/CA2400612C/en not_active Expired - Fee Related
- 2001-02-16 KR KR1020027010697A patent/KR20020092958A/ko not_active Application Discontinuation
- 2001-02-16 DE DE60116855T patent/DE60116855T2/de not_active Expired - Lifetime
- 2001-02-16 US US10/203,918 patent/US6864283B2/en not_active Expired - Fee Related
- 2001-02-16 CZ CZ20022791A patent/CZ20022791A3/cs unknown
- 2001-02-16 AU AU2001233873A patent/AU2001233873B2/en not_active Ceased
- 2001-02-16 PL PL01357193A patent/PL357193A1/xx not_active Application Discontinuation
- 2001-02-16 AT AT01905903T patent/ATE316524T1/de not_active IP Right Cessation
-
2002
- 2002-08-13 IL IL151241A patent/IL151241A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MXPA02007995A (es) | 2003-05-23 |
CA2400612A1 (en) | 2001-08-23 |
ES2256199T3 (es) | 2006-07-16 |
ATE316524T1 (de) | 2006-02-15 |
IL151241A (en) | 2006-10-31 |
EP1255746B1 (en) | 2006-01-25 |
CA2400612C (en) | 2010-05-11 |
CN1318409C (zh) | 2007-05-30 |
KR20020092958A (ko) | 2002-12-12 |
EP1255746A1 (en) | 2002-11-13 |
AU3387301A (en) | 2001-08-27 |
DE60116855D1 (de) | 2006-04-13 |
WO2001060810B1 (en) | 2001-11-29 |
CZ20022791A3 (cs) | 2003-02-12 |
DE60116855T2 (de) | 2006-09-14 |
RU2002124591A (ru) | 2004-01-10 |
PL357193A1 (en) | 2004-07-26 |
CN1423642A (zh) | 2003-06-11 |
AU2001233873B2 (en) | 2006-03-02 |
US6864283B2 (en) | 2005-03-08 |
WO2001060810A1 (en) | 2001-08-23 |
US20030092738A1 (en) | 2003-05-15 |
JP2003523338A (ja) | 2003-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE253051T1 (de) | Chinolinderivate und chinazolinderivate | |
FR18C1006I2 (fr) | Derives de quinoline ayant un groupe azolyle et derives de quinazoline | |
ATE180468T1 (de) | Anthranilsäure derivate | |
MXPA04001240A (es) | Analogos antitumorales. | |
ATE275134T1 (de) | 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel | |
ATE303063T1 (de) | Synthetische analoge des ecteinascidin-743 | |
ATE156836T1 (de) | 11,21-bisphenyl-19-nor-pregnan derivate | |
ATE513821T1 (de) | Thiadiazolin-derivate zur behandlung von krebs | |
ATE204272T1 (de) | Neue pyridon carbonsäure-derivate | |
BR0108448A (pt) | Derivados de tetraidrofuril óxi-e amino-substituìdos com atividade antitumor | |
HK1060354A1 (en) | Variolin derivatives and their use as antitumor agents | |
ATE311182T1 (de) | Benzopyranderivate zur behandlung von perihperer gefässerkrankung | |
TH17157A (th) | อนุพันธ์ไพริมิดีนอะไซโคลนิวคลีโอไซด์ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7O E 8O ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009 |